objective tumor regression was observed in 47 % of patients treated with the ftorafur-methyl-ccnu-methotrexate-bacillus calmette-guerin ( ftor-mem-bcg ) program and in 34 % of patients treated with the 5-fluorouracil-methotrexate-baker 's antifol ( fu-m-baf ) +/- levamisole program .
C0025677
methotrexate
C0280603
fluorouracil-methotrexate